TP53 and cancer: While both cancers share common tumorigenic pathways, including the inactivation of p53 and pRB tumor suppressor proteins by HPV E6 and E7 oncoproteins [204, 205], these disruptions result in increased radiosensitivity in OPSCC but not in CSCC.